Literature DB >> 18449584

Outcome for invasive Staphylococcus aureus infections.

G Jacobsson1, E Gustafsson, R Andersson.   

Abstract

We report a survey of invasive Staphylococcus aureus (ISA) infections concerning outcome variables such as mortality, recurrence and residual symptoms. A prospective, population-based study of all cases of ISA was conducted in the catchment area of Skaraborg Hospital (population 255,109) in western Sweden during the period from 1st March 2003 to 28th February 2005. One hundred and fifty-seven patients were included. Recurrences were seen in 13 cases (9.3%). Thirty patients (19.1%) died during the first 28 days. Mortality rates for complicated bacteraemia and severe sepsis were 32% and 54%, respectively. Older patients (>65 years of age), patients with concomitant heart disease and patients with endovascular infections all suffered higher mortality. Line-associated infections had a higher recurrence rate. Residual symptoms were common, with 34% of the living patients reporting incomplete recovery. Accessory gene regulator (agr) type within the bacteria did not affect disease presentation. We conclude that ISA infections are of major medical importance, with high rates of mortality (19.1%), recurrence (9.3%) and residual functional impairment (34%).

Entities:  

Mesh:

Year:  2008        PMID: 18449584     DOI: 10.1007/s10096-008-0515-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients.

Authors:  V G Fowler; J Li; G R Corey; J Boley; K A Marr; A K Gopal; L K Kong; G Gottlieb; C L Donovan; D J Sexton; T Ryan
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

Review 2.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

Review 4.  Diagnosis and management of Staphylococcus aureus bacteraemia.

Authors:  D H Mitchell; B P Howden
Journal:  Intern Med J       Date:  2005-12       Impact factor: 2.048

Review 5.  Management of bone and joint infections due to Staphylococcus aureus.

Authors:  J S Davis
Journal:  Intern Med J       Date:  2005-12       Impact factor: 2.048

6.  Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality.

Authors:  P C Hill; M Birch; S Chambers; D Drinkovic; R B Ellis-Pegler; R Everts; D Murdoch; S Pottumarthy; S A Roberts; C Swager; S L Taylor; M G Thomas; C G Wong; A J Morris
Journal:  Intern Med J       Date:  2001-03       Impact factor: 2.048

7.  Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?

Authors:  George Sakoulas; George M Eliopoulos; Robert C Moellering; Richard P Novick; Lata Venkataraman; Christine Wennersten; Paola C DeGirolami; Mitchell J Schwaber; Howard S Gold
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

8.  Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections.

Authors:  Kevin B Laupland; Deirdre L Church; Melissa Mucenski; Lloyd R Sutherland; H Dele Davies
Journal:  J Infect Dis       Date:  2003-04-15       Impact factor: 5.226

9.  Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.

Authors:  M C Roghmann
Journal:  Arch Intern Med       Date:  2000-04-10

10.  Virulence factors of Staphylococcus aureus strains causing infective endocarditis--a comparison with strains from skin infections.

Authors:  H Hogevik; B Söderquist; H S Tung; L Olaison; A Westberg; C Rydén; A Tarkowski; R Andersson
Journal:  APMIS       Date:  1998-09       Impact factor: 3.205

View more
  15 in total

1.  [Septic arthritis as an initial manifestation of a bacterial endocarditis].

Authors:  M Gothner; T Ramczykowski; A Ewers; T Kälicke; S Shah; T A Schildhauer; J Swol
Journal:  Unfallchirurg       Date:  2013-05       Impact factor: 1.000

2.  ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.

Authors:  Seth M Daly; Bradley O Elmore; Jeffrey S Kavanaugh; Kathleen D Triplett; Mario Figueroa; Huzefa A Raja; Tamam El-Elimat; Heidi A Crosby; Jon K Femling; Nadja B Cech; Alexander R Horswill; Nicholas H Oberlies; Pamela R Hall
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Antibody responses in patients with invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; P Colque-Navarro; E Gustafsson; R Andersson; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-10       Impact factor: 3.267

4.  Biofilm formation by Staphylococcus aureus clinical isolates correlates with the infection type.

Authors:  Jakub M Kwiecinski; Gunnar Jacobsson; Alexander R Horswill; Elisabet Josefsson; Tao Jin
Journal:  Infect Dis (Lond)       Date:  2019-04-15

Review 5.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Penetration of the blood-brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid.

Authors:  Tamsin R Sheen; Celia M Ebrahimi; Ida H Hiemstra; Steven B Barlow; Andreas Peschel; Kelly S Doran
Journal:  J Mol Med (Berl)       Date:  2010-04-24       Impact factor: 4.599

Review 7.  Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms.

Authors:  Jakub M Kwiecinski; Alexander R Horswill
Journal:  Curr Opin Microbiol       Date:  2020-03-12       Impact factor: 7.934

8.  Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing.

Authors:  Pamela R Hall; Bradley O Elmore; Cynthia H Spang; Susan M Alexander; Brett C Manifold-Wheeler; Moriah J Castleman; Seth M Daly; M Michal Peterson; Erin K Sully; Jon K Femling; Michael Otto; Alexander R Horswill; Graham S Timmins; Hattie D Gresham
Journal:  PLoS Pathog       Date:  2013-02-14       Impact factor: 6.823

9.  A recommendation to perform a blood culture before the administration of intravenous antibiotics increased the detection of Staphylococcus aureus bacteremia.

Authors:  A Jogenfors; L Stark; J Svefors; S Löfgren; B-E Malmvall; A Matussek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-19       Impact factor: 3.267

10.  Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia.

Authors:  Tomi Mölkänen; Eeva Ruotsalainen; Esa M Rintala; Asko Järvinen
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.